Taro Pharmaceutical
TARO
#4675
Rank
HK$12.55 B
Marketcap
HK$334.17
Share price
0.00%
Change (1 day)
7.52%
Change (1 year)

Revenue for Taro Pharmaceutical (TARO)

Revenue in 2023 (TTM): HK$4.78 Billion

According to Taro Pharmaceutical's latest financial reports the company's current revenue (TTM ) is HK$4.75 Billion. an increase over the revenue in the year 2022 that were of HK$4.45 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Taro Pharmaceutical from 1996 to 2023

Annual revenue

Year Revenue Change
2023 HK$4.77 B7.19%
2022 HK$4.45 B0.77%
2021 HK$4.41 B-1.01%
2020 HK$4.46 B-11.83%
2019 HK$5.06 B-2.85%
2018 HK$5.20 B-2.4%
2017 HK$5.33 B-27.4%
2016 HK$7.35 B2.01%
2015 HK$7.20 B15.29%
2014 HK$6.25 B9.35%
2013 HK$5.71 B13.3%
2012 HK$5.04 B28.47%
2011 HK$3.92 B28.77%
2010 HK$3.05 B9.99%
2009 HK$2.77 B
2005 HK$2.34 B6.08%
2004 HK$2.20 B-9.7%
2003 HK$2.44 B48.19%
2002 HK$1.65 B40.94%
2001 HK$1.17 B44.61%
2000 HK$0.80 B24.37%
1999 HK$0.65 B25.96%
1998 HK$0.51 B9.14%
1997 HK$0.47 B8.35%
1996 HK$0.43 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
HK$432.72 B 9,009.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$485.89 B 10,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$682.00 B 14,256.91%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$126.68 B 2,566.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
HK$306.93 B 6,361.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$379.97 B 7,898.98%๐Ÿ‡จ๐Ÿ‡ญ Switzerland